Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99


A rare case of endometrial cancer metastatic to the uveal choroid.

Smith SH, Arudra SKC, Mullen MM, Palisoul M, Dahiya S, Kumar Rao P, Thaker PH.

Gynecol Oncol Rep. 2018 Jan 4;23:24-27. doi: 10.1016/j.gore.2018.01.001. eCollection 2018 Feb.


Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.

Lutgendorf SK, Thaker PH, Arevalo JM, Goodheart MJ, Slavich GM, Sood AK, Cole SW.

Cancer. 2018 Feb 1;124(3):580-586. doi: 10.1002/cncr.31078. Epub 2017 Nov 7.


Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study.

Felix AS, Brasky TM, Cohn DE, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel C, Boggess JF, Pearl ML, Ioffe OB, Deng W, Miller DS, Brinton LA.

Int J Cancer. 2018 Mar 15;142(6):1102-1115. doi: 10.1002/ijc.31127. Epub 2017 Nov 6.


Benefit of combination chemotherapy and radiation stratified by grade of stage IIIC endometrial cancer.

Binder PS, Kuroki LM, Zhao P, Cusworth S, Divine LM, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Massad LS.

Gynecol Oncol. 2017 Nov;147(2):309-314. doi: 10.1016/j.ygyno.2017.08.031. Epub 2017 Sep 13.


Inhibition of the Receptor Tyrosine Kinase AXL Restores Paclitaxel Chemosensitivity in Uterine Serous Cancer.

Palisoul ML, Quinn JM, Schepers E, Hagemann IS, Guo L, Reger K, Hagemann AR, McCourt CK, Thaker PH, Powell MA, Mutch DG, Fuh KC.

Mol Cancer Ther. 2017 Dec;16(12):2881-2891. doi: 10.1158/1535-7163.MCT-17-0587. Epub 2017 Sep 13.


The effect of a multidisciplinary palliative care initiative on end of life care in gynecologic oncology patients.

Mullen MM, Divine LM, Porcelli BP, Wilkinson-Ryan I, Dans MC, Powell MA, Mutch DG, Hagemann AR, Thaker PH.

Gynecol Oncol. 2017 Nov;147(2):460-464. doi: 10.1016/j.ygyno.2017.08.002. Epub 2017 Aug 4.


Diurnal cortisol rhythms, fatigue and psychosocial factors in five-year survivors of ovarian cancer.

Cuneo MG, Schrepf A, Slavich GM, Thaker PH, Goodheart M, Bender D, Cole SW, Sood AK, Lutgendorf SK.

Psychoneuroendocrinology. 2017 Oct;84:139-142. doi: 10.1016/j.psyneuen.2017.06.019. Epub 2017 Jun 30.


Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer.

Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman LD, Wright JD.

Obstet Gynecol. 2017 Aug;130(2):403-410. doi: 10.1097/AOG.0000000000002142.


Yield of Cytology Surveillance After High-Grade Vulvar Intraepithelial Neoplasia or Cancer.

Kuroki LM, Frolova AI, Wu N, Liu J, Powell M, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2017 Jul;21(3):193-197. doi: 10.1097/LGT.0000000000000321.


Changes in spiritual well-being and psychological outcomes in ovarian cancer survivors.

Davis LZ, Cuneo M, Thaker PH, Goodheart MJ, Bender D, Lutgendorf SK.

Psychooncology. 2018 Feb;27(2):477-483. doi: 10.1002/pon.4485. Epub 2017 Aug 4.


Restraint and Social Isolation Stressors Differentially Regulate Adaptive Immunity and Tumor Angiogenesis in a Breast Cancer Mouse Model.

Budiu RA, Vlad AM, Nazario L, Bathula C, Cooper KL, Edmed J, Thaker PH, Urban J, Kalinski P, Lee AV, Elishaev EL, Conrads TP, Flint MS.

Cancer Clin Oncol. 2017 May;6(1):12-24. doi: 10.5539/cco.v6n1p12. Epub 2016 Nov 11.


Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial.

Kuroki LM, Mullen MM, Massad LS, Wu N, Liu J, Mutch DG, Powell MA, Hagemann AR, Thaker PH, McCourt CK, Novetsky AP.

Obstet Gynecol. 2017 Jul;130(1):91-99. doi: 10.1097/AOG.0000000000002061.


Identification of molecular targets in vulvar cancers.

Palisoul ML, Mullen MM, Feldman R, Thaker PH.

Gynecol Oncol. 2017 Aug;146(2):305-313. doi: 10.1016/j.ygyno.2017.05.011. Epub 2017 May 20.


Survival of Cervical Cancer Patients Presenting with Occult Supraclavicular Metastases Detected by FDG-Positron Emission Tomography/CT: Impact of Disease Extent and Treatment.

Ioffe YJ, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH, Schwarz JK, Grigsby PW.

Gynecol Obstet Invest. 2018;83(1):83-89. doi: 10.1159/000458706. Epub 2017 Apr 8.


Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.

Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA.

J Natl Cancer Inst. 2017 Mar 1;109(3):1-10. doi: 10.1093/jnci/djw251.


A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.

Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA 3rd, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D.

Gynecol Oncol. 2017 May;145(2):291-297. doi: 10.1016/j.ygyno.2017.02.040. Epub 2017 Mar 10.


Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients.

Brown AJ, Thaker PH, Sun CC, Urbauer DL, Bruera E, Bodurka DC, Ramondetta LM.

Support Care Cancer. 2017 Jun;25(6):1985-1991. doi: 10.1007/s00520-017-3605-z. Epub 2017 Feb 7.


A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852).

Thaker PH, Salani R, Brady WE, Lankes HA, Cohn DE, Mutch DG, Mannel RS, Bell-McGuinn KM, Di Silvestro PA, Jelovac D, Carter JS, Duan W, Resnick KE, Dizon DS, Aghajanian C, Fracasso PM.

Ann Oncol. 2017 Mar 1;28(3):505-511. doi: 10.1093/annonc/mdw635.


Stress and burnout among gynecologic oncologists: A Society of Gynecologic Oncology Evidence-based Review and Recommendations.

Cass I, Duska LR, Blank SV, Cheng G, duPont NC, Frederick PJ, Hill EK, Matthews CM, Pua TL, Rath KS, Ruskin R, Thaker PH, Berchuck A, Gostout BS, Kushner DM, Fowler JM.

Gynecol Oncol. 2016 Nov;143(2):421-427. doi: 10.1016/j.ygyno.2016.08.319. Epub 2016 Aug 27. Review. No abstract available.


AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.

Divine LM, Nguyen MR, Meller E, Desai RA, Arif B, Rankin EB, Bligard KH, Meyerson C, Hagemann IS, Massad M, Thaker PH, Hagemann AR, McCourt CK, Powell MA, Mutch DG, Fuh KC.

Oncotarget. 2016 Nov 22;7(47):77291-77305. doi: 10.18632/oncotarget.12637.



Binder PS, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA.

Am J Obstet Gynecol. 2017 Feb;216(2):192-193. doi: 10.1016/j.ajog.2016.09.084. Epub 2016 Sep 15. No abstract available.


High-Grade Cervical Dysplasia After Negative Loop Electrosurgical Excision Procedure.

Kuroki LM, James-Nywening L, Wu N, Liu J, Powell MA, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2016 Oct;20(4):300-6. doi: 10.1097/LGT.0000000000000260.


Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.

Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK.

Am J Obstet Gynecol. 2016 Dec;215(6):766.e1-766.e9. doi: 10.1016/j.ajog.2016.07.035. Epub 2016 Jul 22.


See-and-Treat Loop Electrosurgical Excision Procedure for High-Grade Cervical Cytology: Are We Overtreating?

Kuroki LM, Bergeron LM, Gao F, Thaker PH, Massad LS.

J Low Genit Tract Dis. 2016 Jul;20(3):247-51. doi: 10.1097/LGT.0000000000000230.


SSRI use and clinical outcomes in epithelial ovarian cancer.

Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, Ahmed A, Penedo FJ, DeGeest K, Mendez L, Domann F, Sood AK, Lutgendorf SK.

Oncotarget. 2016 May 31;7(22):33179-91. doi: 10.18632/oncotarget.8891.


Clinicopathologic characteristics and survival of patients with gynecologic malignancies metastatic to the brain.

Divine LM, Kizer NT, Hagemann AR, Pittman ME, Chen L, Powell MA, Mutch DG, Rader JS, Thaker PH.

Gynecol Oncol. 2016 Jul;142(1):76-82. doi: 10.1016/j.ygyno.2016.04.030. Epub 2016 May 8.


Reply to beta blockers in epithelial ovarian cancer and beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?

Thaker PH, Urbauer DL, Sood AK.

Cancer. 2016 Jan 15;122(2):325-6. doi: 10.1002/cncr.29723. Epub 2015 Oct 7. No abstract available.


Postmenopausal Invasive Endometriosis Requiring Supralevator Pelvic Exenteration.

Klenov VE, Potretzke TA, Sehn JK, Thaker PH.

Obstet Gynecol. 2015 Dec;126(6):1215-8. doi: 10.1097/AOG.0000000000000998.


Clinical impact of selective and nonselective beta-blockers on survival in patients with ovarian cancer.

Watkins JL, Thaker PH, Nick AM, Ramondetta LM, Kumar S, Urbauer DL, Matsuo K, Squires KC, Coleman RL, Lutgendorf SK, Ramirez PT, Sood AK.

Cancer. 2015 Oct 1;121(19):3444-51. doi: 10.1002/cncr.29392. Epub 2015 Aug 24.


Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.

Kizer NT, Hatem H, Nugent EK, Zhou G, Moore K, Heller P, Mutch DG, Thaker PH.

Int J Gynecol Cancer. 2015 Jul;25(6):1015-22. doi: 10.1097/IGC.0000000000000453.


Eudaimonic well-being and tumor norepinephrine in patients with epithelial ovarian cancer.

Davis LZ, Slavich GM, Thaker PH, Goodheart MJ, Bender DP, Dahmoush L, Farley DM, Markon KE, Penedo FJ, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Cancer. 2015 Oct 1;121(19):3543-50. doi: 10.1002/cncr.29516. Epub 2015 Jun 10.


Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer.

Kuroki LM, Benn TE, Dukes JL, Hagemann AR, Thaker PH, Powell MA, Mutch DG, Massad LS, Zighelboim I.

Gynecol Oncol Rep. 2015 Apr;12:41-44.


Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients.

Brown AJ, Sun CC, Urbauer DL, Bodurka DC, Thaker PH, Ramondetta LM.

Gynecol Oncol. 2015 Aug;138(2):388-93. doi: 10.1016/j.ygyno.2015.05.005. Epub 2015 May 16.


A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): an NRG Oncology/Gynecologic Oncology Group study.

McMeekin DS, Sill MW, Walker JL, Moore KN, Waggoner SE, Thaker PH, Rizack T, Hoffman JS, Fracasso PM.

Gynecol Oncol. 2015 Jul;138(1):36-40. doi: 10.1016/j.ygyno.2015.04.038. Epub 2015 May 6.


A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group study.

Coleman RL, Sill MW, Thaker PH, Bender DP, Street D, McGuire WP, Johnston CM, Rotmensch J.

Gynecol Oncol. 2015 Jul;138(1):30-5. doi: 10.1016/j.ygyno.2015.04.005. Epub 2015 Apr 14.


Diurnal cortisol and survival in epithelial ovarian cancer.

Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Psychoneuroendocrinology. 2015 Mar;53:256-67. doi: 10.1016/j.psyneuen.2015.01.010. Epub 2015 Jan 20.


Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing.

Frolova AI, Babb SA, Zantow E, Hagemann AR, Powell MA, Thaker PH, Gao F, Mutch DG.

Gynecol Oncol. 2015 Apr;137(1):7-13. doi: 10.1016/j.ygyno.2015.01.535. Epub 2015 Jan 21.


Targeting those with decreased meaning and peace: a supportive care opportunity.

Brown AJ, Sun CC, Urbauer D, Zhukovsky DS, Levenback C, Frumovitz M, Thaker PH, Bodurka DC, Ramondetta LM.

Support Care Cancer. 2015 Jul;23(7):2025-32. doi: 10.1007/s00520-014-2568-6. Epub 2014 Dec 18.


Neoadjuvant chemotherapy versus primary cytoreductive surgery for stage IV uterine serous carcinoma.

Wilkinson-Ryan I, Frolova AI, Liu J, Stewart Massad L, Thaker PH, Powell MA, Mutch DG, Hagemann AR.

Int J Gynecol Cancer. 2015 Jan;25(1):63-8. doi: 10.1097/IGC.0000000000000321.


Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.

Kuroki LM, Mangano M, Allsworth JE, Menias CO, Massad LS, Powell MA, Mutch DG, Thaker PH.

Ann Surg Oncol. 2015 Mar;22(3):972-9. doi: 10.1245/s10434-014-4040-8. Epub 2014 Sep 5.


A case of ovarian cancer metastases causing a symptomatic paraesophageal hernia.

Wolfe M, Wilkinson-Ryan I, Hagemann AR, Thaker PH.

Am J Obstet Gynecol. 2014 Nov;211(5):568.e1-2. doi: 10.1016/j.ajog.2014.07.040. Epub 2014 Jul 25. No abstract available.


A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients.

Novetsky AP, Zighelboim I, Guntupalli SR, Ioffe YJ, Kizer NT, Hagemann AR, Powell MA, Thaker PH, Mutch DG, Massad LS.

Gynecol Oncol. 2014 Aug;134(2):233-7. doi: 10.1016/j.ygyno.2014.06.012. Epub 2014 Jun 18.


Etiology and workup of fevers in gynecologic oncology patients.

McCartney SA, Sabo MC, Massad LS, Hagemann AR, Mutch DG, Powell MA, Thaker PH, Novetsky AP.

Int J Gynecol Cancer. 2014 Jun;24(5):950-5. doi: 10.1097/IGC.0000000000000129.


Postradiation damage to the pelvic girdle in cervical cancer patients: is intensity-modulated radiation therapy safer than conventional radiation?

Ioffe YJ, Hillen TJ, Zhou G, Schwarz JK, Massad LS, Powell MA, Hagemann AR, Mutch DG, Thaker PH.

Int J Gynecol Cancer. 2014 May;24(4):806-12. doi: 10.1097/IGC.0000000000000117.


The prognostic significance of lymphovascular space invasion in laparoscopic versus abdominal hysterectomy for endometrioid endometrial cancer.

Dewdney SB, Jiao Z, Roma AA, Gao F, Rimel BJ, Thaker PH, Powell MA, Massad LS, Mutch DG, Zighelboim I.

Eur J Gynaecol Oncol. 2014;35(1):7-10.


A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: a gynecologic oncology group study.

Campos SM, Brady WE, Moxley KM, O'Cearbhaill RE, Lee PS, DiSilvestro PA, Rotmensch J, Rose PG, Thaker PH, O'Malley DM, Hanjani P, Zuna RE, Hensley ML.

Gynecol Oncol. 2014 Jun;133(3):537-41. doi: 10.1016/j.ygyno.2014.02.036. Epub 2014 Mar 1. Erratum in: Gynecol Oncol. 2014 Dec;135(3):624.


Disclosing a diagnosis of cancer: considerations specific to gynecologic oncology patients.

Kuroki LM, Zhao Q, Jeffe DB, Powell MA, Hagemann AR, Thaker PH, Massad LS, Mutch DG, Zighelboim I.

Obstet Gynecol. 2013 Nov;122(5):1033-9. doi: 10.1097/AOG.0b013e3182a9bf42.


Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer.

Hagemann AR, Novetsky AP, Zighelboim I, Gao F, Massad LS, Thaker PH, Powell MA, Mutch DG, Wright JD.

Gynecol Oncol. 2013 Dec;131(3):535-40. doi: 10.1016/j.ygyno.2013.09.032. Epub 2013 Oct 4.


Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients.

Lutgendorf SK, Slavich GM, Degeest K, Goodheart M, Bender D, Thaker PH, Penedo F, Zimmerman B, Lucci J 3rd, Mendez L, Collins K, Sood AK.

Gynecol Oncol. 2013 Dec;131(3):667-73. doi: 10.1016/j.ygyno.2013.09.025. Epub 2013 Oct 3.

Supplemental Content

Loading ...
Support Center